On the Street: Chelsea
During the pandemic, Chelsea was hit particularly hard. Local community organizations are trying to help their community as many struggle with food insecurity. (Video by Shelby Lum/Globe Staff, Photo by David L Ryan/Globe Staff)

More business headlines

GM flips to California’s side in pollution fight with Trump

General Motors says it will no longer support the Trump administration in legal efforts to end California’s right to set its own clean-air standards.

COVID-19 testing in Mass. is ‘far short’ of levels needed to stop the spread

At a Monday meeting, the Massachusetts High Technology Council recommended that federal, state, and local governments develop a systematic, expanded testing regime using multiple kinds of tests.


Logan now offers COVID-19 tests for passengers

XpresCheck has set up a modular facility inside Terminal E and can administer more than 400 tests a day.

Vaccine Tracker

Live tracker: Coronavirus vaccines to keep an eye on

Here's a list of notable COVID-19 vaccine candidates worth watching, reflecting a snapshot of companies and efforts that have ties to New England, have major funding behind them and the ability to move markets, and reflect a diversity of approaches to tackling the novel coronavirus pandemic.

Cambridge startup wants to use ‘natural killer’ cells to fight cancer

Catamaran Bio, unveiled Monday, has been quietly incubating at LabCentral in Cambridge since July and has $42 million raised by five venture capital firms.

Mass. hospital officials warn against large holiday gatherings

In a letter to the public, nearly 100 chief medical officers and chief nursing officers joined the chorus of health experts and public officials already raising alarms about the potential for coronavirus to spread more rapidly because of the Thanksgiving holiday.

Astra delivers but can’t match rivals. Here’s what we know

The pressure was on AstraZeneca Plc and the University of Oxford after stunning COVID-19 vaccine trial results from Pfizer Inc. and Moderna Inc., and the UK partners delivered, even if they couldn’t match the data from the two front-runners.

AstraZeneca: COVID-19 vaccine ‘highly effective’ prevention

AstraZeneca said Monday that late-stage trials showed that its COVID-19 vaccine with Oxford University was up to 90 percent effective in preventing disease.